Dr Sarah Walsh s.walsh@rgu.ac.uk
Research Fellow
Cannabidiol and CBD oil for prevention of cardiac dysfunction
People Involved
Dr Nadine Godsman
Professor Cherry Wainwright c.wainwright@rgu.ac.uk
Professor
Project Description
Cannabidiol (CBD) has cardioprotective properties against the outcome of myocardial ischaemia and reperfusion. CBD oil, which contains not only cannabidiol but a host of biologically active molecules that may also offer some benefits to cardiac health, is used clinically for management of neuropathic pain and other similar conditions. This project aims to compare the effects of pure CBD and CBD oil in cell and in vivo models of cardiac remodelling that occurs in response to pathological stimuli such as after a heart attack, in diabetes and cardiotoxic chemotherapeutic agents.
| Status | Project Live |
|---|---|
| Funder(s) | MRX Medical Ltd |
| Value | £95,076.00 |
| Project Dates | Mar 9, 2023 - Dec 19, 2024 |
You might also like
sFRPs as a novel modulator of diastolic heart failure Oct 1, 2017 - Dec 31, 2021
Following a heart attack, or because of persistently high blood pressure the heart is damaged and has to work harder to circulate blood around the body. This condition is known as heart failure. In the UK alone, 500,000 people have heart failure re...
Read More about sFRPs as a novel modulator of diastolic heart failure.
The in vitro effect of natural products and anti-cancer agents: targeting the efflux transporter ABCG2 Jul 1, 2017 - Dec 31, 2019
Medicinal use of natural products, such as, extracts from plants have existed for many years particularly in China and are now widely available around the world. Several different types of cancer including breast cancer are becoming insensitive and r...
Read More about The in vitro effect of natural products and anti-cancer agents: targeting the efflux transporter ABCG2.
Defining the emerging roles of GPR55 Oct 1, 2019 - Feb 4, 2023
The G-protein coupled receptor (GPCR) superfamily play crucial roles in cell communication. Given their involvement in neurological disorders, inflammatory and metabolic diseases, diabetes and cardiac dysfunction they represent the largest and most s...
Read More about Defining the emerging roles of GPR55.
Extracting added value from the Seaweed Industry - a search for novel anti-obesity agents Oct 1, 2018 - Dec 31, 2022
Seaweed farming is a growing industry in the UK, with the majority of the biomass being used for the extraction of high yield products such as aliginates, or for use as biofuels.
However, a significant amount of the biomass remains un-used and t...
Read More about Extracting added value from the Seaweed Industry - a search for novel anti-obesity agents.